RecruitingPhase 3NCT07100990
Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)
Studying Autoimmune/inflammatory optic neuropathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Mayo Clinic
- Principal Investigator
- John ChenMayo Clinic
- Intervention
- High-dose corticosteroids (HDCS)(drug)
- Enrollment
- 382 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2031
Study locations (24)
- Mayo Clinic Arizona, Scottsdale, Arizona, United States
- University of Colorado - Anschutz Medical, Aurora, Colorado, United States
- Yale University School of Medicine, North Haven, Connecticut, United States
- Mayo Clinic Florida, Jacksonville, Florida, United States
- University of Illinois Chicago, Chicago, Illinois, United States
- Northwestern University, Evanston, Illinois, United States
- Indiana University, Indianapolis, Indiana, United States
- University of Maryland, Baltimore, Baltimore, Maryland, United States
- Johns Hopkins University, Baltimore, Maryland, United States
- Harvard University Massachusetts General Hospital, Boston, Massachusetts, United States
- Boston Medical Center, Boston, Massachusetts, United States
- Mayo Clinic in Rochester, Rochester, Minnesota, United States
- University of Mississippi Medical Center, Jackson, Mississippi, United States
- Icahn School of Medicine at Mount Sinai, New York, New York, United States
- Weill Cornell Medical College, New York, New York, United States
- +9 more locations on ClinicalTrials.gov
Collaborators
Patient-Centered Outcomes Research Institute
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07100990 on ClinicalTrials.gov